Stanford’s world-leading department of anesthesia offers comprehensive training in perioperative patient care, pain management and critical care medicine. Our program aims to train expert clinicians, future leaders in the field of anesthesia, and clinician-scientists who will expand our knowledge of the specialty through basic science and translational discoveries.
Gerald Reaven, who coined ‘Syndrome X,’ dies
Gerald Reaven’s decades of research at Stanford helped show that insulin resistance could lead to Type 2 diabetes and multiple other diseases.
A detailed look at school revenue, expenses
Among other things, the School of Medicine meeting focused on the costs of facilities maintenance and the formula for funding departments, programs and support for faculty.
Low-fat or low-carb? It’s a draw
Stanford researchers have found that, contrary to previous studies, insulin levels and a specific genotype pattern don’t predict weight-loss success.
Scope blog debuts new look
Stanford Medicine’s award-winning blog, Scope, has a refreshed, mobile-friendly design.
Seizure-regulating nerve cells identified
Stanford researchers have found that a small set of nerve cells in the brain regulates the debilitating seizures and cognitive deficits characteristic of the most common form of epilepsy in adults. This discovery could lead to new and better treatments.
Conferences and Workshops
New courses are added regularly— please check back often
Join the Mailing List
New activities are added regularly. Join our mailing list to receive notifications about activities of interest to you.
Related Clinical Trials
Showing 1 - 20 of 41 trials
Non-Invasive Measurement of Hemoglobin (Using Pulse Co-Oximetry) in Patients Undergoing Elective Cesarean DeliveryStanford is currently not accepting patients for this trial.
Using the SEDLine for the Titration of Sevoflurane in Elderly Patients Recovery Using the SEDLine TM for the Titration of Sevoflurane in Elderly Patients Undergoing Non-Cardiac Surgery After Beta-Adrenergic BlockadeStanford is currently not accepting patients for this trial.